UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 52

of 'Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-sensitive disease'

52
TI
PARP inhibitors for targeted treatment in ovarian cancer.
AU
Dizon DS
SO
Lancet. 2017;
 
AD
Women's Cancers, Lifespan Cancer Institute, Medical Oncology, Rhode Island Hospital, Medicine, Alpert Medical School of Brown University, Providence, RI 02903, USA. Electronic address: don.dizon@Lifespan.org.
PMID